男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

US may OK 'mix-and-match' vaccine boosters

By MINLU ZHANG in New York | China Daily Global | Updated: 2021-10-20 10:22
Share
Share - WeChat
Johnson & Johnson's coronavirus disease (COVID-19) vaccines are seen at Northwell Health's South Shore University Hospital in Bay Shore, New York, March 3, 2021. [Photo/Agencies]

The US Food and Drug Administration (FDA) this week may approve giving people COVID-19 vaccine booster shots that are different from their first doses, according to numerous media reports.

The FDA is planning to make the announcement Wednesday as part of its authorization of boosters for the Moderna and Johnson & Johnson vaccines, according to The New York Times.

People familiar with the agency's plans say it won't recommend one vaccine over another, and it may say that it is best to use the same vaccine as a booster, according to the Times. But vaccine providers can decide to offer different brands at their discretion, the Times said. The decision would meet requests of state health officials who have been seeking to increase the flexibility in giving the vaccines.

An advisory committee of the Centers for Disease Control and Prevention (CDC) will discuss the booster issue on Thursday, and the agency will then issue its own recommendations. By this weekend, tens of millions of Americans could be eligible for additional injections.

Last week, a panel of experts advising the FDA recommended booster shots of the J&J vaccine, a day after voting in favor of the Moderna booster.

The same committee received the results of a "mix-and-match" study that showed recipients of the J&J vaccine would receive enhanced protection from a second dose of the Moderna or Pfizer vaccine, which relies on a different technology. 

The FDA last month authorized booster shots of the Pfizer-BioNTech vaccine for at least six months after the second dose.

According to an analysis published by the CDC on Tuesday, the Pfizer-BioNTech vaccine, the only one approved in the US for those 17 and under, was 93 percent effective at keeping people age 12 to 18 out of the hospital.

"This evaluation demonstrated that two doses of Pfizer-BioNTech vaccine are highly effective at preventing COVID-19 hospitalization among persons aged 12–18 years," the agency's scientists wrote.

The agency studied 464 young people who were hospitalized at 19 pediatric hospitals across 16 states from June through September. While roughly 72 percent of them had at least one underlying condition that increased their potential for severe symptoms, researchers found that 97 percent of those who ended up in the hospital weren't vaccinated.

Washington State football coach Nick Rolovich was dismissed Monday after he declined to get vaccinated against COVID-19 despite a statewide mandate issued in August by Democratic Governor Jay Inslee. 

"Nick is not eligible to be employed at Washington State University, through noncompliance," Athletic Director Pat Chun said Monday night.

The university also fired four assistant coaches for not complying with the mandate.

Rolovich was the state's highest-paid employee at $3.2 million per year, The Washington Post reported. 

He hadn't obtained approval for an exemption by Monday's state deadline. Rolovich had requested a religious exemption to comply with the mandate and didn't elaborate on his religious reasons for not being vaccinated, USA Today reported.

The Seattle Times reported that after Saturday night's 34-31 victory over Stanford, Rolovich said: "I don't think this is in my hands. I've been settled for a long time on it. … If that's not what [Chun] wants, then I guess I've got to move on. But I like being here, I like being the coach here. I love these kids."

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 张北县| 文昌市| 梅河口市| 湘阴县| 长丰县| 葵青区| 商都县| 南城县| 资溪县| 沧州市| 安阳县| 莱西市| 专栏| 合川市| 邯郸市| 北票市| 荆门市| 青神县| 嘉禾县| 湘潭县| 新密市| 开化县| 长垣县| 五常市| 上林县| 东宁县| 布拖县| 高淳县| 会东县| 平潭县| 沅陵县| 诸暨市| 象山县| 株洲市| 安图县| 高清| 兰溪市| 巴林左旗| 颍上县| 卫辉市| 慈溪市| 土默特右旗| 聂荣县| 安徽省| 磴口县| 淮北市| 武功县| 科技| 灌南县| 化德县| 临漳县| 宁波市| 建始县| 深圳市| 平度市| 洞头县| 泸定县| 阿城市| 城口县| 保定市| 东港市| 阳谷县| 九龙县| 信宜市| 永靖县| 哈尔滨市| 重庆市| 汕头市| 清流县| 苏尼特右旗| 宜阳县| 黎城县| 临夏县| 南雄市| 西安市| 汪清县| 通渭县| 湛江市| 连江县| 大新县| 贵港市| 峡江县|